Håkan Larsson

Title: Håkan Larsson: Innovator in Allergy Research

Introduction

Håkan Larsson is a notable inventor based in Bälinge, Sweden. He has made significant contributions to the field of allergy research, particularly in the development of novel allergens. His work has implications for both diagnosis and therapy of Type I allergies.

Latest Patents

Håkan Larsson holds a patent related to a novel horse allergen. This invention consists of a heterodimeric protein with a first peptide chain and a second peptide chain, which together have an overall sequence identity of at least 70% with the combined sequences of SEQ ID NO:3 and SEQ ID NO:4. Additionally, it includes a single chain protein with a similar sequence identity. The invention is aimed at improving methods of diagnosis and therapy for Type I allergies, along with the development of kits and compositions for these methods. He has 1 patent to his name.

Career Highlights

Håkan Larsson is associated with Phadia AB, a company known for its advancements in allergy diagnostics. His role at the company has allowed him to focus on innovative solutions for allergy-related health issues.

Collaborations

Håkan has collaborated with notable colleagues such as Lars Mattsson and Ulrica Olsson, contributing to the advancement of research in allergy diagnostics and treatment.

Conclusion

Håkan Larsson's work in developing novel allergens represents a significant step forward in allergy research. His contributions are vital for improving diagnostic and therapeutic methods for Type I allergies.